FAM161B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.18330000026457E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.87639999982281E-07 |
Normal-vs-Stage2 |
1.636450E-02 |
Normal-vs-Stage3 |
1.011780E-01 |
Normal-vs-Stage4 |
1.361970E-01 |
Stage1-vs-Stage2 |
8.617800E-01 |
Stage1-vs-Stage3 |
1.473400E-01 |
Stage1-vs-Stage4 |
7.870600E-01 |
Stage2-vs-Stage3 |
4.097200E-01 |
Stage2-vs-Stage4 |
9.147600E-01 |
Stage3-vs-Stage4 |
5.939600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.12149999997868E-06 |
Normal-vs-AfricanAmerican |
1.22359999998878E-06 |
Normal-vs-Asian |
2.780800E-03 |
Caucasian-vs-AfricanAmerican |
3.903200E-01 |
Caucasian-vs-Asian |
6.761800E-01 |
AfricanAmerican-vs-Asian |
8.863800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.49519999714798E-08 |
Normal-vs-Female |
3.652200E-02 |
Male-vs-Female |
1.117890E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
5.6268000000026E-05 |
Normal-vs-Extreme_Weight |
1.05940000105775E-08 |
Normal-vs-Obese |
1.077830E-02 |
Normal-vs-Extreme_Obese |
4.715700E-02 |
Normal_Weight-vs-Extreme_Weight |
5.119000E-01 |
Normal_Weight-vs-Obese |
1.370030E-01 |
Normal_Weight-vs-Extreme_Obese |
7.978600E-01 |
Extreme_Weight-vs-Obese |
1.356390E-02 |
Extreme_Weight-vs-Extreme_Obese |
5.152000E-01 |
Obese-vs-Extreme_Obese |
5.346200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.137530E-02 |
Normal-vs-Age(41-60Yrs) |
3.828300E-04 |
Normal-vs-Age(61-80Yrs) |
2.42240000281058E-08 |
Normal-vs-Age(81-100Yrs) |
6.955600E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.655000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.160200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.952200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.272300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.960200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.621400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.28990000294971E-08 |
Normal-VS-Type2 PRCC |
6.624300E-03 |
Normal-VS-KIRP CIMP |
8.498200E-02 |
Normal-VS-Unclassified PRCC |
1.093190E-01 |
Type1 PRCC-VS-Type2 PRCC |
8.704100E-02 |
Type1 PRCC-VS-KIRP CIMP |
7.940200E-01 |
Type1 PRCC-VS-Unclassified PRCC |
9.504200E-02 |
Type2 PRCC-VS-KIRP CIMP |
6.208800E-01 |
Type2 PRCC-VS-Unclassified PRCC |
6.832800E-01 |
KIRP CIMP-VS-Unclassified PRCC |
4.890200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.3474999999995E-05 |
Normal-vs-N1 |
2.272400E-01 |
Normal-vs-N2 |
8.26340000000814E-05 |
N0-vs-N1 |
1.009620E-01 |
N0-vs-N2 |
3.801800E-01 |
N1-vs-N2 |
1.523000E-01 |
|
|